UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 6, 2018 5:00 P.M.
Form:
F-1
CIK:
0001023549
Company Name:
XTL BIOPHARMACEUTICALS LTD
File Number:
333-208817